Antibodies under a microscope

DHC98801

Research Grade Natalizumab

Description

AN 100226, BG00002, CAS: 189261-10-7

Targets

ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4

Isotype/Mimetic

IgG4-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression